Sarcoidosis Associated Pulmonary Hypertension: Clinical Trials

1 trial for Sarcoidosis Associated Pulmonary Hypertension, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Not yet recruiting 1

Follow Sarcoidosis Associated Pulmonary Hypertension: new trials by email Literature Review of Sarcoidosis Associated Pulmonary Hypertension trials Research Report on Sarcoidosis Associated Pulmonary Hypertension

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
LAM-001 for the Treatment of Sarcoidosis Associated Pulmonary Hypertension (SAPH)
Placebo, LAM-001 - Sarcoidosis Associated Pulmonary Hypertension
Phase 2Not yet recruitingIRulya Therapeutics Inc.602026-12-012026-10-21

Narrower conditions

Sarcoidosis (1)

Broader conditions

Hemic and Lymphatic Diseases (1)  ·  Hypersensitivity (1)  ·  Hypersensitivity, Delayed (1)  ·  Immune System Diseases (1)  ·  Lymphatic Diseases (1)  ·  Lymphoproliferative Disorders (1)

Sponsors

IRulya Therapeutics Inc. (1)

Countries

United States (1)